BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34948449)

  • 1. Recent Advances in the Inhibition of the IL-4 Cytokine Pathway for the Treatment of Allergen-Induced Asthma.
    Massey O; Suphioglu C
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commonality of the IL-4/IL-13 pathway in atopic diseases.
    Gandhi NA; Pirozzi G; Graham NMH
    Expert Rev Clin Immunol; 2017 May; 13(5):425-437. PubMed ID: 28277826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma and Atopic Dermatitis: A Review of Targeted Inhibition of Interleukin-4 and Interleukin-13 As Therapy for Atopic Disease.
    Buzney CD; Gottlieb AB; Rosmarin D
    J Drugs Dermatol; 2016 Feb; 15(2):165-71. PubMed ID: 26885783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.
    Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ
    Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab utility in difficult-to-treat asthma.
    M Walsh G
    Immunotherapy; 2019 Mar; 11(4):261-264. PubMed ID: 30678554
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergen-induced Th1 and Th2 cytokine secretion in relation to specific allergen sensitization and atopic symptoms in children.
    Jenmalm MC; Van Snick J; Cormont F; Salman B
    Clin Exp Allergy; 2001 Oct; 31(10):1528-35. PubMed ID: 11678852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen-induced cytokine secretion in atopic and non-atopic asthmatic children.
    Böttcher MF; Bjurström J; Mai XM; Nilsson L; Jenmalm MC
    Pediatr Allergy Immunol; 2003 Oct; 14(5):345-50. PubMed ID: 14641603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma.
    Oh CK; Geba GP; Molfino N
    Eur Respir Rev; 2010 Mar; 19(115):46-54. PubMed ID: 20956165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites.
    Bao L; Alexander JB; Shi VY; Mohan GC; Chan LS
    Immunology; 2014 Dec; 143(4):601-8. PubMed ID: 24943510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4/interleukin-13 versus interleukin-5: a comparison of molecular targets in biologic therapy for the treatment of severe asthma.
    Wu AY; Sur S; Grant JA; Tripple JW
    Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):30-37. PubMed ID: 30407206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelidonine, a principal isoquinoline alkaloid of Chelidonium majus, attenuates eosinophilic airway inflammation by suppressing IL-4 and eotaxin-2 expression in asthmatic mice.
    Kim SH; Hong JH; Lee YC
    Pharmacol Rep; 2015 Dec; 67(6):1168-77. PubMed ID: 26481537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL13 variants are associated with total serum IgE and early sensitization to food allergens in children with atopic dermatitis.
    Zitnik SE; Rüschendorf F; Müller S; Sengler C; Lee YA; Griffioen RW; Meglio P; Wahn U; Witt H; Nickel R
    Pediatr Allergy Immunol; 2009 Sep; 20(6):551-5. PubMed ID: 19220774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.
    Ghaffar O; Christodoulopoulos P; Lamkhioued B; Wright E; Ihaku D; Nakamura Y; Frenkiel S; Hamid Q
    Clin Exp Allergy; 2000 Jan; 30(1):86-93. PubMed ID: 10606935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4 receptor α blockade prevents sensitization and alters acute and long-lasting effects of allergen-specific immunotherapy of murine allergic asthma.
    Russkamp D; Aguilar-Pimentel A; Alessandrini F; Gailus-Durner V; Fuchs H; Ohnmacht C; Chaker A; de Angelis MH; Ollert M; Schmidt-Weber CB; Blank S
    Allergy; 2019 Aug; 74(8):1549-1560. PubMed ID: 30829405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Results of Specific IgE in 100 Atopic Dermatitis Patients with the Use of Multiplex Examination ALEX2-Allergy Explorer.
    Čelakovská J; Bukač J; Cermákova E; Vaňková R; Skalská H; Krejsek J; Andrýs C
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of allergic skin wheal responses in patients with atopic eczema/dermatitis syndrome by playing video games or by a frequently ringing mobile phone.
    Kimata H
    Eur J Clin Invest; 2003 Jun; 33(6):513-7. PubMed ID: 12795649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of plasma interleukin-8 in atopic dermatitis.
    Kimata H; Lindley I
    Arch Dis Child; 1994 Feb; 70(2):119-22. PubMed ID: 8129432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of allergen-specific sublingual immunotherapy in atopic dermatitis.
    Mastrandrea F
    Am J Clin Dermatol; 2004; 5(5):281-94. PubMed ID: 15554729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of IL-4 receptor alpha on smooth muscle cells is not necessary for development of experimental allergic asthma.
    Kirstein F; Horsnell WG; Kuperman DA; Huang X; Erle DJ; Lopata AL; Brombacher F
    J Allergy Clin Immunol; 2010 Aug; 126(2):347-54. PubMed ID: 20579713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL-4R) in allergic diseases.
    Nasert S; Millner M; Herz U; Lack G; Wahn U; Gelfand EW; Renz H
    Behring Inst Mitt; 1995 Jun; (96):118-30. PubMed ID: 7575347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.